When complement first contacts salivary secretions, as when gingival crevicular fluid first meets saliva at the gingival margin, complement function is enhanced. The immediate potentiation of the complement system at equal volume ratios of serum to saliva is due to several factors, including the lower ionic strength of saliva when compared with serum and the presence of certain salivary glyproteins such as the nonimmunoglobulin agglutinins that appear to simultaneously activate Cl and affect (sequester) certain complement control proteins, such as Factor H.
This initial potentiation of the complement cascade by saliva may aid in defending the area immediately above the gingival crevice from oral microbiota that are being coated with a combination of serous exudate components and salivary components.
As serum becomes much more diluted with saliva (i.e., crevicular fluid moves away from the supragingival area), the acidic proline-rich salivary proteins (APRP) begin to disrupt the unbound Clq-Clr2-Cls2 macromolecular complexes. Thus, the APRP along with other C1 fixing substances in saliva appear to restrict complement function, but only when the ratios of saliva to serum exceed 250 :1.
Since certain salivary glycoproteins bind to viruses, the potentiation of the complement system by saliva may also play a role in neutralizing certain viral infections on mucosal surfaces where tissue transudates containing complement begin to contact mucosal secretions such as saliva. Again, the ratio of serous fluid to mucosal secretion appears to be an important factor.
This article also discusses some of our preliminary data and speculations concerning the binding of the self-associating high-molecular-weight nonimmunoglobulin salivary agglutinins (NIA) with the envelope of the human immunodeficiency virus (HIV) and the possible cooperative role of Clq and fibronectin in aiding neutralization of HIV infectivity.
References
1.
Thomas, S.G., Boackle, R.J., Long, K., Lass, J., and Medof, M.E., Identification and isolation of two forms of decay accelerating factor (DAF) from parotid saliva, FASEB. J., 4, 2852, 1990.
2.
Boackle, R., Pruitt, K., and Mestecky, J., The interactions of human complement with interfacially aggregated preparations of human secretory IgA, Immunochemistry, 11, 543, 1974.
3.
O'Lee, T.W., Boackle, R.J., and Wang, A.C., Blockage of selected salivary mediated agglutination reactions by non-specific aggregated Fab fragments of IgG, in Protides of the Biological Fluids, XXXII Colloquium, Peeters, H., Ed., Pergamon Press, New York, 1985, 305.
4.
Vesely, J. and Boackle, R.J., The interaction of C1 with non-immunoglobulin agglutinins, Complement Workshop abstract, Complement and Inflammation, 6, 409, 1989.
5.
Boackle, R.J. and Connor, M.H., Aggregated non-immunoglobulin salivary agglutinins for bacteria (SBA) activate the first component of complement, presented at International Association of Dental Research, Montreal, Canada, March 1988.
6.
O'Lee, T.W. and Boackle, R.J., The effects of aggregated IgG and IgG-immune complexes on the agglutination of bacteria mediated by non-immunoglobulin salivary agglutinins, Arch. Oral Biol., 32, 539, 1987.
7.
Courts, F.J., Boackle, R.J., Silverman, M.S., and Fudenberg, H.H., Detection of functional complement components in gingival crevicular fluid from humans with periodontal disease, J. Dent. Res., 56, 327, 1977.
8.
Schenkein, H.A. and Genco, R.J., Gingival fluid and serum in periodontal disease. II. Evidence for cleavage of complement components C3, C3 proactivator (Factor B) and C4 in gingival fluid, J. Periodont. Res., 48, 778, 1977.
9.
Schenkein, H.A. and Genco, R.J., Gingival fluid and serum in periodontal diseases. I. Quantitative study of immunoglobulins, complement components, and other plasma proteins, J. Periodont. Res., 48, 772, 1977.
10.
Niekrash, C.E. and Patters, M.R., Simultaneous assessment of complement components C3, C4 and B and their cleavage products in human gingival fluid. II. Longitudinal changes during periodontal therapy, J. Peridont. Res., 20, 268, 1985.
11.
Niekrash, C.E. and Patters, M.R., Assessment of complement cleavage in gingival fluid in humans with and without periodontal disease, J. Periodont. Res., 21, 233, 1986.
12.
Niekrash, C.E. and Patters, M.R., Simultaneous assessment of complement components C3, C4 and B and their cleavage products in human gingival fluid. I. Reliability of the method, J. Periodont. Res., 20, 260, 1983.
13.
Shillitoe, E.J. and Lehner, T., Immunoglobulin and complement in crevicular fluid; serum and saliva in man, Arch. Oral Biol., 17, 241, 1972.
14.
Chisikovsky, J., Toto, P.D., and Gargiulo, A.W., Clq and C4 detection on bacterial plaque organisms, J. Periodont., 53, 688, 1982.
Lamster, I.B., Application of new methodology to the study of gingival crevicular fluid, in New Biotechnology in Oral Research, Myers, H. M., Ed., S. Karger, Basel, 1989, 90.
17.
Fultz, P.N., Components of saliva inactivate human immunodeficiency virus, Lancet Z, 1215, 1986.
18.
Fox, P.C., Wolff, A., Yeh, C.-K., Atkinson, J.C., and Baum, B.J., Saliva inhibits HIV-1 infectivity, J. Am. Dent. Assoc., 116, 635, 1988.
19.
Fox, P.C., Wolff, A., Yeh, C.-K., Atkinson, J.C., and Baum, B.J., Salivary inhibition of HIV-1 infectivity: functional properties and distribution in men, women and children, J. Am. Dent. Assoc., 118, 709, 1989.
20.
Boackle, R.J., Vesely, J., Bonewald, L., and Wang, A.C., Restriction of C1 hemolytic function by human proline rich salivary proteins, Mol. Immunol., 21,415, 1984.
21.
Albrechtsen, O.K. and Thaysen, J.H., Fibrinolytic activity in human saliva, Acta, Phys. Scand., 34, 138, 1955.
22.
Bruckner, G.C., The effect of reduced oxygen partial pressure in inhaled air on the release of bio-active substances in human saliva, Arch. Oral Biol., 17, 465, 1972.
23.
Chandler, J.W., Leder, R., Kaufman, H.F., and Caldwell, J.r., Quantitative determinations of complement components and immunoglobulins in tears and aqueous humor, Invest. Opthalmol. Vis. Sci., 13, 151, 1974.
24.
Yamamoto, G.K. and Allansmith, M.R., Complement in tears from normal humans, Am. J. Ophthalmol., 88, 758, 1979.
25.
Nakajima, S., Baba, A.S., and Tamura, N., Complement system in human colostrum. Presence of nine complement components and factors of alternative pathway in human colostrum, Int. Arch. Allergy Appl. Immunol., 54, 428, 1977.
26.
Bluestone, R., Easty, D.L., Goldberg, L.S., Jones, B.R., and Pettit, T.H., Lacrimal immunoglobulins and complement quantified by counter-immunoelectrophoresis, Br. J. Ophthalmol., 59, 279, 1975.
27.
D'Cruz, Osmond, Haas, Gilbert, G., and Lambert, H., Evaluation of antisperm complement-dependent immune mediators in human ovarian follicular fluid, J. Immunol., 144, 3841, 1990.
28.
Eggert, F.M., Salivary and amniotic-fluid agglutinin and aggregating factors: evidence for complexing between high-molecular weight non-mucin glycoproteins and immunoglobulins, Biochem. Soc. Trans., 7, 194, 1979.
29.
Eggert, F.M., The nature of secretory agglutinins and aggregating factors. I. Secretory conglutinin-like factors, secretory bacterial aggregating factors and secretory IgA antibody in human saliva and amniotic fluid, Int. Arch. Allergy Appl. Immunol., 61, 192, 1980.
30.
Lachmann, P.J. and Thomson, R.A., Immunoconglutinins in human saliva - a group of unusual IgA antibiodies, Immunology, 18, 157, 1970.
31.
Boackle, R.J., Caughman, G.B., and Carsgo, E.A., The partial isolation and function of salivary factors which interact with the complement system: a possible role in mucosal immunity, Adv. Exp. Biol., 107, 411, 1978.
32.
Williams, B.D., Challacombe, S.J., Slaney, J.M., Lachman, P.J., and Lehner, T., Immunoconglutinins and C3 in human saliva, Clin. Exp. Immunol., 19, 423, 1975.
33.
Eggert, F.M., Bacterial aggregating and conglutinin-like factors in human saliva and amniotic fluid: investigations of molecular size, Biochem. Soc. Trans., 7, 193, 1979.
Wirtz, G.H., Price, R.A., Mutchler, B.A., and Miller, R.W., The first component of complement as a constituent of human salivary sediment, Arch. Oral. Biol., 32, 505, 1987.
36.
Lally, E.T., McArthur, W.P., and Baehni, P.C., Biosynthesis of complement in chronically inflamed gingiva, J. Periodont. Res., 17, 257, 1982.
37.
Boackle, R.J., The complement system, in Introduction to Medical Immunology, 2nd ed., Virella, G., Goust, J. M., and Fudenberg, H. H., Eds., Marcel Dekker, New York, 1990, 143.
38.
Ziccardi, R.J., The role of immune complexes in the activation of the first component of human complement, J. Immunol., 132, 283, 1984.
39.
Lin, T.S. and Fletcher, E.S., Activation of Clr and C1s subcomponents of human complement C1 by the third component Clq, J. Biol. Chem., 255, 7756, 1980.
40.
Ziccardi, R.J. and Cooper, N., Active disassembly of the first complement component, C1, by C1-inactivator, J. Immunol., 123, 788, 1979.
41.
Sim, R.B., Arlaud, G.J., and Colomb, M.G., C1-inhibitor-dependent dissociation of human complement component C1 bound to immune complexes, Biochem. J., 179, 449, 1979.
42.
Ziccardi, R.J., A new role for Cl-inhibitor in homeostasis: control of activation of the first component of human complement, J. Immunol., 128, 2505, 1982.
43.
Cooper, N.R., Activation and regulation of the first complement component, Fed. Proc., 42, 134, 1983.
44.
Boackle, R.J. and Suddick, R.P., Salivary proteins, in The Biological Basis of Dental Caries, A Textbook of Oral Biology, Manaker, L., Ed., Harper & Row, New York, 1980, 113.
45.
Boackle, R.J., Pruitt, K.M., Silverman, M.S., and Glymph, J.L., Jr., The effects of human saliva on the hemolytic activity of complement, J. Dent. Res., 57, 103, 1978.
46.
Chang, N.S. and Boackle, R.J., An unusual complement hemolytic kinetics at low ionic strength, Mol. Immunol., 22, 1217, 1985.
47.
Chang, N.S. and Boackle, R.J., Glycosaminoglycans enhance complemnt hemolytic efficiency: theoretical considerations for GAG-complement-saliva interactions, Mol. Immunol., 23, 887, 1986.
48.
Boackle, R.J., Johnson, B.J., and Caughman, G.B., An IgG primary sequences exposure theory for complement activation using synthetic peptides, Nature, 282, 742, 1979.
49.
Bennick, A., Cannon, M., and Madapallimattam, G., The nature of the hydroxyapatite-binding site in salivary acidic proline-rich proteins, Biochem. J., 183, 115, 1989.
50.
Malamud, D., Applebaum, B., Kline, R., and Golub, E.E., Bacterial aggregating activity in human saliva: comparison of bacterial species and strains, Infect. Immun., 31, 1003, 1981.
51.
Rundegren, J., Caclium-dependent salivary agglutinin with reactivity to various oral bacterial species, Infect. Immun., 53, 173, 1986.
52.
Rundegren, J. and Arnold, R.R., Differentiation and interaction of secretory immunoglobulin A and a calcium-dependent parotid agglutinin for several bacterial strains, Infect. Immun., 55, 288, 1987.
53.
Ericson, T. and Arwin, H.H., Molecular basis of saliva-mediated aggregation, p. 114, in Mergenhagen, S. E. and Rosan, B., Eds., Molecular Basis of Oral Microbial Adhesion, American Society for Microbiology, Washington, D.C., 1985.
54.
Gibbons, R.J., Bacterial adhesion to oral tissues: a model for infectious diseases, J. Dent. Res., 68, 750, 1989.
55.
Ericson, T. and Rundegren, J., Characterization of a salivary agglutinin reacting with a serotype C strain of Streptoccus mutans, Eur. J. Biochem., 133, 255, 1983.
56.
Robinovitch, M.R., Malamud, D., Rosan, B., Golub, E.E., and Lancy, P., Jr., Identification of Streptococcus sanguis receptor for salivary agglutinins, J. Dent. Res., 65, 98, 1986.
57.
Gibbons, R.J. and Hay, D.I., Human salivary acidic proline rich proteins and statherin promote the attachment of Actinomycis viscosus LY7 to apatitic surface, Infect. Immunity, 56, 439, 1988.
58.
Rundegren, J. and Ericson, T., Effect of calcium on reactions between a salivary agglutinin and serotype c strain of Streptococcus mutans, J. Oral Pathol., 10, 269, 1981.
59.
Virella, G., Goudswaard, J., and Boackle, R.J., Levels of lysozmye and immunoglobulins in total and parotid saliva from normal adults, Clin. Chem., 24, 1421, 1978.
60.
Kievits, F. and Kujlstra, A., Complement regulation in tears, in Protides of the Biological Fluids, Vol. 32, 1984, 31.
61.
Coleman, R.D. and Appleman, M.D., Antibodies of syphilis in saliva and serum, J. Dent. Res., 32, 294, 1953.
62.
Klauder, J.V. and Kolmer, J.A., Wasserman test with secretions, transudates and exudates, JAMA, 76, 1635, 1921.
63.
Wheatcroft, M.G., Comparative study of human serum and salivary antibody titers in cases of Brucella melitensis infections, J. Dent. Res., 36, 112, 1957.
64.
Kraus, F.W. and Konno, J., The salivary secretion of antibody, Alab. J. Med. Sci., 2, 15, 1965.
65.
Cartwright, T., The plasminogen activator of vampire bat saliva, Blood, 43, 317, 1974.
66.
Last, K.S., Stanbury, J.B., and Embery, G., Glycoaminoglycans in human crevicular fluid as indicators of active periodontal disease, Arch. Oral Biol., 30, 275, 1985.
67.
Embery, G., Oliver, W.M., Stanbury, J.B., and Purvis, J.A., The electrophoretic detection of acidic glycosaminoglycans in human gingival sulcus fluid, Arch. Oral Biol., 27, 177, 1982.
68.
Boackle, R.J., Vesely, J., and Lindstrom, C.D., Reversal of Ca++ mediated anticomplementary effects by increased specific antibody, J. Dent. Res., (Spec. Iss.), 68, 409, 1989.
69.
Caughman, G.B., Boackle, R.J., and Vesely, J., A postulated mechanism for heparin's potentiation of C1 inhibitor function, Mol. Immunol., 19, 287, 1982.
70.
Boackle, R.J., Caughman, G.B., Vesely, J., Medgyesi, G., and Fudenberg, H.H., Potentiation of Factor H by heparin: a rate-limiting mechanism for inhibition of the alternative complement pathway, Mol. Immunol., 20(11), 1157, 1983.
71.
Hay, D.I., Gibbons, R.J., and Spinell, D.M., Characteristics of some high molecular weight constituents with bacterial aggregating activity from whole saliva and dental plaque, Caries Res., 5, 111, 1971.
72.
Ericson, T., Carlen, A., and Dagerskog, E., Salivary aggregating factors, in Stiles, H. M., Loesche, W. J., and O'Brien, T. C. 0., Eds., Proceedings, Microbial Aspects of Dental Caries (a special supplement to Microbiology Abstracts), Vol. 1, Information Retrieval, Inc., Washington, D.C., 1976.
73.
Price, J.F., Williams, B.D., and Challacombe, S.J., Anti-C3 antibodies in neonatal saliva, Nature, 257, 146, 1975.
74.
O'Lee, T.W. and Boackle, R.J., The interaction of Factor H and salivary agglutinating factors, J. Dent. Res., 64 (Abstr. 712), 1985.
75.
Su, H. and Boackle, R.J., Binding of Clq to recombinant gpl60, FASEB J., 4, A2089, 1990.
76.
Linde, A., Bergham, L.E., Hamsson, H.-A., Jonsson, R., and Redfors, Y., Ultrastructual localization of fibronectin in duct cells of human minor salivary glands and its immunochemical detection in minor salivary gland secretion, Arch. Oral Biol., 29, 921, 1984.
77.
Tynelius-Bratthall, G., Ericson, D., and Araujo, H.M., Fibronectin in saliva and gingival crevices, J. Periodont. Res., 21, 563, 1986.
78.
Julkunen, I., Vartio, T., and Keski-Oja, J., Localization of viral-envelope-glycoprotein-binding sites in fibronectin, Biochem. J., 219, 425, 1984.
79.
Weill, J.C., Leca, G., Girard, J.F., and Ayed, K., Inactivation of complement by mouse saliva enzymatic degradation of C2, C3, C4, C5 and C7, Clin. Immunol. Immunopathol., 12, 425, 1979.
80.
Wallace, L.J., Partlow, L.M., and Ellis, M.E., a-Adrenergic regulation of the secretion of an anticomplementary factor in mouse saliva, Proc. Soc. Exp. Biol. Med., 152, 92, 1976.
81.
Okuda, K. and Takazoe, I., Activation of complement by dental plaque, J. Periodont. Res., 15, 232, 1980.
82.
Tsai, C.C., Nilson, U.R., MacArthur, W.P., and Taichman, N.S., Activation of the complement system by some gram positive oral bacteria, Arch. Oral Biol., 22, 309, 1977.
